Mbx Biosciences Inc (MBX)

Feb 11, 2026

MBX Biosciences execs join Feb–Mar health investor events - Stock Titan

Feb 11, 2026

Feb 11, 2026

MBX Biosciences to Participate in Upcoming Investor Conferences - The Manila Times

Feb 11, 2026

Feb 08, 2026

Profit Recap: Is MBX Biosciences Inc being accumulated by smart moneyWeekly Market Report & Community Driven Trade Alerts - baoquankhu1.vn

Feb 08, 2026

Feb 06, 2026

MBX Biosciences raises $87.1 million through at-the-market stock offering - Investing.com UK

Feb 06, 2026

Feb 05, 2026

MBX Biosciences raises $87.1 million through at-the-market stock offering By Investing.com - Investing.com South Africa

Feb 05, 2026

Feb 05, 2026

MBX Biosciences Raises $87 Million in ATM Offering - TipRanks

Feb 05, 2026

Feb 04, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 04, 2026

Feb 03, 2026

MBX Biosciences (NASDAQ:MBX) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Feb 03, 2026

Feb 03, 2026

Universal Beteiligungs und Servicegesellschaft mbH Takes Position in MBX Biosciences, Inc. $MBX - MarketBeat

Feb 03, 2026

Feb 01, 2026

A Look At MBX Biosciences (MBX) Valuation After New Barclays Overweight Coverage - Sahm

Feb 01, 2026

Jan 31, 2026

How Investors Are Reacting To MBX Biosciences (MBX) Adding Veteran CFO Laurie Stelzer To Its Board - Sahm

Jan 31, 2026

Jan 30, 2026

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech Bet With 65.85% Upside Potential - DirectorsTalk Interviews

Jan 30, 2026

Jan 30, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Short Interest Update - MarketBeat

Jan 30, 2026

Jan 29, 2026

MBX Biosciences (NASDAQ:MBX) Now Covered by Analysts at Barclays - MarketBeat

Jan 29, 2026

Jan 28, 2026

Barclays Initiates Coverage on MBX Biosciences With Overweight Rating - marketscreener.com

Jan 28, 2026

Jan 27, 2026

How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% - MSN

Jan 27, 2026

Jan 24, 2026

Risk Off: Is MBX Biosciences Inc part of any ETF2025 Biggest Moves & Growth Focused Entry Point Reports - baoquankhu1.vn

Jan 24, 2026

Jan 23, 2026

MBX SEC FilingsMBX Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jan 23, 2026

Jan 23, 2026

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 42.85% Upside in Biotech Innovation - DirectorsTalk Interviews

Jan 23, 2026

Jan 23, 2026

Assessing MBX Biosciences (MBX) Valuation After A 261% One Year Total Shareholder Return - Yahoo Finance

Jan 23, 2026

Jan 23, 2026

MBX Biosciences appoints Laurie Stelzer to board of directors By Investing.com - Investing.com Nigeria

Jan 23, 2026

Jan 22, 2026

MBX Biosciences, Inc. Announces Board and Committee Changes - marketscreener.com

Jan 22, 2026

Jan 22, 2026

MBX Biosciences appoints Laurie Stelzer to board of directors - Investing.com

Jan 22, 2026

Jan 22, 2026

MBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair - TipRanks

Jan 22, 2026

Jan 22, 2026

MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair - The Manila Times

Jan 22, 2026

Jan 22, 2026

Forecast Cut: Should I buy MBX Biosciences Inc stock nowEarnings Overview Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Jan 22, 2026

Jan 21, 2026

MBX Biosciences (NASDAQ:MBX) Shares Down 6.8%Here's What Happened - MarketBeat

Jan 21, 2026

Jan 21, 2026

Assessing MBX Biosciences (MBX) Valuation After Guggenheim’s Supportive Obesity Drug Updates - Sahm

Jan 21, 2026

Jan 18, 2026

Is MBX Biosciences’ (MBX) Once‑Monthly Obesity Strategy Quietly Redefining Its Competitive Moat? - Sahm

Jan 18, 2026

Jan 18, 2026

Will MBX Biosciences Inc. stock benefit from upcoming earnings reportsWeekly Investment Report & Long Hold Capital Preservation Tips - bollywoodhelpline.com

Jan 18, 2026

Jan 17, 2026

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Teladoc (TDOC) and Pfizer (PFE) - The Globe and Mail

Jan 17, 2026

Jan 16, 2026

Guggenheim raises MBX Biosciences stock price target on obesity drug potential - Investing.com Nigeria

Jan 16, 2026

Jan 14, 2026

MBX Biosciences Surges Amid Strategic Partnership Developments - timothysykes.com

Jan 14, 2026

Jan 13, 2026

Breakout Watch: What makes MBX Biosciences Inc stock attractive to growth fundsEarnings Summary Report & Real-Time Buy Zone Alerts - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Stifel reiterates Buy rating on MBX Biosciences stock, citing obesity drug pipeline - Investing.com Canada

Jan 13, 2026

Jan 13, 2026

Stifel reiterates Buy rating on MBX Biosciences stock, citing obesity drug pipeline By Investing.com - Investing.com Nigeria

Jan 13, 2026

Jan 12, 2026

MBX Biosciences (NASDAQ:MBX) Trading 7.6% HigherTime to Buy? - MarketBeat

Jan 12, 2026

Jan 12, 2026

MBX Biosciences Sees Shares Surge amid Strategic Partnerships - timothysykes.com

Jan 12, 2026

Jan 12, 2026

MBX Biosciences Highlights 2026 Outlook and Pipeline Progress - TipRanks

Jan 12, 2026

Jan 12, 2026

Portfolio Shifts: Is MBX Biosciences Inc stock influenced by commodity pricesJuly 2025 Earnings & Fast Moving Trade Plans - baoquankhu1.vn

Jan 12, 2026

Jan 11, 2026

Mbx Biosciences Says Phase 3 Trial Of Canvuparatide To Start In Q3 2026 - TradingView — Track All Markets

Jan 11, 2026

Jan 11, 2026

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference - Sahm

Jan 11, 2026

Jan 11, 2026

Drug maker maps out once-monthly obesity shots and hormone disorder trial - Stock Titan

Jan 11, 2026

Jan 10, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 10, 2026